Inventor · disambiguated record
Binhua Lv
Also filed as: LV BINHUA
21 granted patents·10 pending applications·145 citations·filing 2007–2023
94Inventor score
Files withSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD16THERACOS INC5THERACOS SUB LLC4CHEN YUANWEI3CAI MENGZHUANG1
Top patents by PatentIndex Score
31 records- 0193US7838499B2Benzylbenzene derivatives and methods of useTHERACOS INC·Filed 2008·Granted Nov 23, 2010·35 cites·31 claims
- 0292US8106021B2Benzylbenzene derivatives and methods of useCHEN YUANWEI·Filed 2010·Granted Jan 31, 2012·24 cites·23 claims
- 0391US11459327B1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Granted Oct 4, 2022·6 cites·6 claims
- 0490US10981942B2Crystalline form of benzylbenzene SGLT2 inhibitorTHERACOS SUB LLC·Filed 2019·Granted Apr 20, 2021·3 cites·10 claims
- 0589US8987323B2Crystalline form of benzylbenzene SGLT2 inhibitorCAI MENGZHUANG·Filed 2011·Granted Mar 24, 2015·17 cites·14 claims
- 0689US7838498B2Benzylic glycoside derivatives and methods of useTHERACOS INC·Filed 2008·Granted Nov 23, 2010·19 cites·37 claims
- 0788US9193751B2Process for the preparation of benzylbenzene SGLT2 inhibitorsTHERACOS INC·Filed 2013·Granted Nov 24, 2015·4 cites·36 claims
- 0886US9725478B2Process for the preparation of benzylbenzene SGLT2 inhibitorsTHERACOS SUB LLC·Filed 2015·Granted Aug 8, 2017·2 cites·2 claims
- 0986US8802637B2Benzylbenzene derivatives and methods of useTHERACOS INC·Filed 2013·Granted Aug 12, 2014·7 cites·7 claims
- 1085US10533032B2Crystalline form of benzylbenzene SGLT2 inhibitorTHERACOS SUB LLC·Filed 2017·Granted Jan 14, 2020·4 cites·20 claims
- 1184US9834573B2Crystalline form of benzylbenzene SGLT2 inhibitorTHERACOS SUB LLC·Filed 2015·Granted Dec 5, 2017·4 cites·26 claims
- 1281US8575321B2Benzylbenzene derivatives and methods of useCHEN YUANWEI·Filed 2011·Granted Nov 5, 2013·5 cites·7 claims
- 1380US9061060B2Deuterated benzylbenzene derivatives and methods of useSEED BRIAN·Filed 2009·Granted Jun 23, 2015·5 cites·33 claims
- 1477US9809572B2Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compoundsSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Nov 7, 2017·5 cites·16 claims
- 1572US9604935B2Deuterated phenyl amino pyrimidine compound and pharmaceutical composition containing the sameSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2014·Granted Mar 28, 2017·3 cites·11 claims
- 1667US10544185B2Deuterated chenodeoxycholic acid derivative and pharmaceutical composition comprising compound thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Jan 28, 2020·1 cites·17 claims
- 1765US10377725B2Phenyl amino pyrimidine compound or polymorph of salt thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2016·Granted Aug 13, 2019·1 cites·15 claims
- 1863US2023105745A1Cycloalkyl and hetero-cycloalkyl inhibitors, preparation methods therefor, and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1963US2025206758A1Substituted bridged ring inhibitor, preparation method therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2061US2025051444A1Multi-specific t cell engagers comprising lrrc15 antigen-binding domainSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2154US10618884B2Deuterated diaminopyrimidine compounds and pharmaceutical compositions comprising such compoundsSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2017·Granted Apr 14, 2020·0 cites·18 claims
- 2254US2024002362A1Deuterated 2-arylheterocycle-3-oxo-2,3- dihydropyridazine-4-carboxamide inhibitor and preparation method therefor and application thereofSHANGHAI ZELGEN PHARMA TECH CO LTD·Filed 2021·Application pending·0 cites
- 2353US2024336606A1Substituted benzo or pyridopyrimidine amine inhibitor, preparation method therefor, and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2452US2023118795A1Aryl or heteroaryl pyridone or pyrimidine derivative, preparation method and use thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2021·Application pending·0 cites
- 2552US2023008368A1Imidazoquinoline substituted phosphoric ester agonist, and preparation therefor and application thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2651US2025376449A1Preparation process for jaktinib dihydrochloride monohydrateSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 2747US8129434B2Benzylphenyl cyclohexane derivatives and methods of useCHEN YUANWEI·Filed 2008·Granted Mar 6, 2012·0 cites·28 claims
- 2847US2022162256A1Method for preparing chenodeoxycholic acid derivativeSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 2946US7803778B2Glucose transport inhibitors and methods of useTHERACOS INC·Filed 2007·Granted Sep 28, 2010·0 cites·29 claims
- 3046US2023109134A1Pyridazinone or pyridazine compound and derivative and pharmaceutical composition thereofSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2020·Application pending·0 cites
- 3133US10414767B2Deuterated quinazolinone compound and pharmaceutical composition comprising sameSUZHOU ZELGEN BIOPHARMACEUTICALS CO LTD·Filed 2015·Granted Sep 17, 2019·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when Binhua Lv files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →